Supplementary Table 10 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Barbara Stefanska,Jian Huang,Bishnu Bhattacharyya,Matthew Suderman,Michael Hallett,Ze-Guang Han,Moshe Szyf

DOI: https://doi.org/10.1158/0008-5472.22391234

2023-01-01

Abstract:Excel file - 263K, List of genes in the heatmap showing hierarchical clustering between cancer and normal samples in Fig. 1A.

What problem does this paper attempt to address?

Supplementary Table 12 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Barbara Stefańska,Jikun Huang,Bishnu Bhattacharyya,Matthew Suderman,Michael Hallett,Ze‐Guang Han,Moshe Szyf

DOI: https://doi.org/10.1158/0008-5472.22391228

2023-01-01

Abstract:Excel file - 286K, List of genes in the heatmap in Fig. 3A.
Supplementary Table 7 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Barbara Stefanska,Jian Huang,Bishnu Bhattacharyya,Matthew Suderman,Michael Hallett,Ze-Guang Han,Moshe Szyf

DOI: https://doi.org/10.1158/0008-5472.22391207.v1

2023-01-01

Abstract:PDF file - 827K, List of genes that are heavily methylated in normal liver and become demethylated in HCC.
Supplementary Table 4 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Barbara Stefańska,Jikun Huang,Bishnu Bhattacharyya,Matthew Suderman,Michael Hallett,Ze‐Guang Han,Moshe Szyf

DOI: https://doi.org/10.1158/0008-5472.22391219

2023-01-01

Abstract:PDF file - 17K, List of 19 promoters corresponding to 12 genes whose promoter hypomethylation may have been a result of deletion/amplification.
Supplementary Table 2 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Barbara Stefanska,Jian Huang,Bishnu Bhattacharyya,Matthew Suderman,Michael Hallett,Ze-Guang Han,Moshe Szyf

DOI: https://doi.org/10.1158/0008-5472.22391225

2023-01-01

Abstract:PDF file - 10K, Primer sequences used in mathylation analysis by pyrosequencing.
Supplementary Table 9 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Barbara Stefańska,Jikun Huang,Bishnu Bhattacharyya,Matthew Suderman,Michael Hallett,Ze‐Guang Han,Moshe Szyf

DOI: https://doi.org/10.1158/0008-5472.22391201

2023-01-01

Abstract:PDF file - 15K, List of 83 genes whose expression was examined in HepG2 and SkHep1 cells after MBD2 knockdown.
Supplementary Methods from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Barbara Stefanska,Jian Huang,Bishnu Bhattacharyya,Matthew Suderman,Michael Hallett,Ze-Guang Han,Moshe Szyf

DOI: https://doi.org/10.1158/0008-5472.22391243.v1

2023-01-01

Abstract:PDF file - 106K
Supplementary Figure 5 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Barbara Stefańska,Jikun Huang,Bishnu Bhattacharyya,Matthew Suderman,Michael Hallett,Ze‐Guang Han,Moshe Szyf

DOI: https://doi.org/10.1158/0008-5472.22391255.v1

2023-01-01

Abstract:PDF file - 923K, Expression and DNA methylation characteristics in normal liver cells of genes that become hypomethylated in HCC. The distribution of promoter methylation levels (A) and gene expression (B) in normal liver tissue for genes that are hypomethylated and induced, hypomethylated but not induced, induced but not hypomethylated in HCC in comparison with the distribution of the state of methylation and expression in the entire population of genes in normal liver. * The lists of genes hypomethylated and induced in liver cancer that are highly methylated (categories 6, 7, 8) and lowly expressed (categories 1, 2) in normal liver.
Supplementary Figure 1 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Barbara Stefanska,Jian Huang,Bishnu Bhattacharyya,Matthew Suderman,Michael Hallett,Ze-Guang Han,Moshe Szyf

DOI: https://doi.org/10.1158/0008-5472.22391267.v1

2023-01-01

Abstract:PDF file - 3033K, Validation of MeDIP microarray results by pyrosequencing (A) and Affymetrix expression array results by QPCR (B) for selected genes in cancer and normal samples from 11 HCC patients. The demethylated genes in liver cancer were identified based on methylation microarrays. The probes that demonstrated lower methylation levels in cancer compared to adjacent normal tissue as shown in the array tracks, were chosen for validation by pyrosequencing. The position of each CpG site relative to the transcription start site is depicted in a physical map for each of the genes. All results represent mean S.D. of two or three independent experiments; ***P < 0.001, **P <0.01, *P <0.05.
Supplementary Figure 7 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Barbara Stefanska,Jian Huang,Bishnu Bhattacharyya,Matthew Suderman,Michael Hallett,Ze-Guang Han,Moshe Szyf

DOI: https://doi.org/10.1158/0008-5472.22391249

2023-01-01

Abstract:PDF file - 609K, (A,B) Expression of genes that are affected by MBD2 depletion in addition to those shown in Fig. 5 in: (A) HepG2 and SkHep1 cancer cells and NorHep cells; (B) HepG2 and SkHep1 cells after MBD2 knockdown. All results represent mean S.D. of two or three independent experiments; ***P < 0.001, **P <0.01, *P <0.05.
Supplementary Table 1 from Genome-Wide Study of Hypomethylated and Induced Genes in Patients with Liver Cancer Unravels Novel Anticancer Targets

Barbara Stefanska,David Cheishvili,Matthew Suderman,Ani Arakelian,Jian Huang,Michael Hallett,Ze-Guang Han,Mamun Al-Mahtab,Sheikh Mohammad Fazle Akbar,Wasif Ali Khan,Rubhana Raqib,Imrana Tanvir,Haseeb Ahmed Khan,Shafaat A. Rabbani,Moshe Szyf

DOI: https://doi.org/10.1158/1078-0432.22452299.v1

2023-01-01

Abstract:XLS file - 32KB, Supplementary Table S1. List of siRNAs, shRNAs, primer sequences used in expression analysis (QPCR) and pyrosequencing.
Supplementary Table 1 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Humam Kadara,Li Shen,Junya Fujimoto,Pierre Saintigny,Chi-Wan Chow,Wenhua Lang,Zuoming Chu,Melinda Garcia,Mohamed Kabbout,You-Hong Fan,Carmen Behrens,Diane A. Liu,Li Mao,J. Jack Lee,Kathryn A. Gold,Jing Wang,Kevin R. Coombes,Edward S. Kim,Waun Ki Hong,Ignacio I. Wistuba

DOI: https://doi.org/10.1158/1940-6207.22524609.v1

2023-01-01

Abstract:XLSX file - 68K, Supplementary table depicting 1165 genes significantly differentially expressed by site in the molecular field of injury
Additional File 16: Table S15. of the Signature of Liver Cancer in Immune Cells DNA Methylation

Yonghong Zhang,Sophie Petropoulos,Jinhua Liu,David Cheishvili,Rudy Zhou,Sergiy Dymov,Kang Li,Ning Li,Moshe Szyf

DOI: https://doi.org/10.6084/m9.figshare.5802096

2018-01-01

Abstract:Descriptive statistics for (Fig. 6a). (XLS 87 kb)
Additional File 17: Table S16. of the Signature of Liver Cancer in Immune Cells DNA Methylation

Yonghong Zhang,Sophie Petropoulos,Jinhua Liu,David Cheishvili,Rudy Zhou,Sergiy Dymov,Kang Li,Ning Li,Moshe Szyf

DOI: https://doi.org/10.6084/m9.figshare.5802114

2018-01-01

Abstract:Clinical data of first cohort. (XLSX 18 kb)
Supplemental Table S6-9 from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

De-Chen Lin,Anand Mayakonda,Huy Q. Dinh,Pinbo Huang,Lehang Lin,Xiaoping Liu,Ling-wen Ding,Jie Wang,Benjamin P. Berman,Er-Wei Song,Dong Yin,H. Phillip Koeffler

DOI: https://doi.org/10.1158/0008-5472.22416156

2023-01-01

Abstract:Files containing results related to methylation ITH
Additional File 7: Table S3. of Global Analysis of DNA Methylation in Hepatocellular Carcinoma by a Liquid Hybridization Capture-Based Bisulfite Sequencing Approach

Fei Gao,Huifang Liang,Hanlin Lu,Junwen Wang,Meng Xia,Zhimei Yuan,Yu Yao,Tong Wang,Xiaolong Tan,Arian Laurence,Hui Xu,Jingjing Yu,Wei Xiao,Wei Chen,Ming Zhou,Xiuqing Zhang,Qian Chen,Xiaoping Chen

DOI: https://doi.org/10.6084/m9.figshare.c.3638753_d12

2015-01-01

Abstract:Summary of 77 genes containing DMRs across at least 6 pairs of HCCs and non-tumors by LHC-BS.
Aberrant DNA Methylation Patterns of Deleted in Liver Cancer 1 Isoforms in Hepatocellular Carcinoma

Junhai Pan,Duguang Li,Xiaoxiao Fan,Jiaxi Cheng,Shengxi Jin,Peng Chen,Hui Lin,Yirun Li

DOI: https://doi.org/10.1089/dna.2022.0384

2023-01-01

DNA and Cell Biology

Abstract:Hepatocellular carcinoma (HCC), a common primary liver cancer, is the third leading cause of death worldwide. DNA methylation changes are common in HCC and have been studied to be associated with hepatocarcinogenesis. In our study, we used the MassARRAY® EpiTYPER technology to investigate the methylation differences of deleted in liver cancer 1 (DLC1) (isoform 1 and 3) promoter between HCC tissues and corresponding adjacent noncancerous tissues and the association between methylation levels and clinicopathological features. In addition, the modified CRISPR-Cas9 system and the DNA methyltransferase inhibitor (DNMTi) were utilized to explore the functional correlation of epigenetic modifications and DLC1 gene regulation. The methylation levels of the DLC1 isoforms in HCC samples were found significantly lower than those in the adjacent noncancerous tissues (all p < 0.0001). Also, we found that the expression of DLC1 could be bidirectionally regulated by the modified CRISPR-Cas9 system and the DNMTi. Moreover, the hypomethylation of DLC1 in HCC samples was connected with the presence of satellite lesions (p = 0.0305) and incomplete tumor capsule (p = 0.0204). Receiver operator characteristic curve analysis demonstrated that the methylation levels of DLC1 could be applied to discriminate HCC patients (area under the curve = 0.728, p < 0.0001). The hypomethylation status was a key regulatory mechanism of DLC1 expression and might serve as a potential biomarker for HCC.
Additional File 13 of Pan-cancer Analysis Revealed H3K4me1 at Bivalent Promoters Premarks DNA Hypermethylation During Tumor Development and Identified the Regulatory Role of DNA Methylation in Relation to Histone Modifications

Lu Yang,Qiang Cao,Yue Yu,Yazhou Sun,Xuan Jiang,Xin Li

DOI: https://doi.org/10.6084/m9.figshare.22757346

2023-01-01

Abstract:Additional file 13: Supplementary Table S1. Summary of 5 gene groups in different cancer types.
Additional File 12: Table S11. of Identification of Prognostic Signature in Cancer Based on DNA Methylation Interaction Network

Wei‐Lin Hu,Xionghui Zhou

DOI: https://doi.org/10.6084/m9.figshare.5728614

2017-01-01

Abstract:Samples in the training and test sets of breast cancer. (XLSX 14 kb)
Supplementary Data from Methylation of tip30 Promoter is Associated with Poor Prognosis in Human Hepatocellular Carcinoma

Bin Lü,Yunchao Ma,Guobin Wu,Xin Tong,Haipeng Guo,Anmin Liang,Cong Wang,Chang Liu,Hao Wang,Mengchao Wu,Jun Zhao,Yajun Guo

DOI: https://doi.org/10.1158/1078-0432.22439469

2023-01-01

Abstract:Supplementary Data from Methylation of Tip30 Promoter Is Associated with Poor Prognosis in Human Hepatocellular Carcinoma
Supplementary Table S4 from Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level

Yingcheng Wu,Shuaixi Yang,Jiaqiang Ma,Zechuan Chen,Guohe Song,Dongning Rao,Yifei Cheng,Siyuan Huang,Yifei Liu,Shan Jiang,Jinxia Liu,Xiaowu Huang,Xiaoying Wang,Shuangjian Qiu,Jianmin Xu,Ruibin Xi,Fan Bai,Jian Zhou,Jia Fan,Xiaoming Zhang,Qiang Gao

DOI: https://doi.org/10.1158/2159-8290.22540405

2023-01-01

Abstract:Supplementary Table S4. Macrophage phenotypic gene signature.

Supplementary Table 10 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Supplementary Table 12 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Supplementary Table 7 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Supplementary Table 4 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Supplementary Table 2 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Supplementary Table 9 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Supplementary Methods from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Supplementary Figure 5 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Supplementary Figure 1 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Supplementary Figure 7 from Definition of the Landscape of Promoter DNA Hypomethylation in Liver Cancer

Supplementary Table 1 from Genome-Wide Study of Hypomethylated and Induced Genes in Patients with Liver Cancer Unravels Novel Anticancer Targets

Supplementary Table 1 from Characterizing the Molecular Spatial and Temporal Field of Injury in Early-Stage Smoker Non–Small Cell Lung Cancer Patients after Definitive Surgery by Expression Profiling

Additional File 16: Table S15. of the Signature of Liver Cancer in Immune Cells DNA Methylation

Additional File 17: Table S16. of the Signature of Liver Cancer in Immune Cells DNA Methylation

Supplemental Table S6-9 from Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

Additional File 7: Table S3. of Global Analysis of DNA Methylation in Hepatocellular Carcinoma by a Liquid Hybridization Capture-Based Bisulfite Sequencing Approach

Aberrant DNA Methylation Patterns of Deleted in Liver Cancer 1 Isoforms in Hepatocellular Carcinoma

Additional File 13 of Pan-cancer Analysis Revealed H3K4me1 at Bivalent Promoters Premarks DNA Hypermethylation During Tumor Development and Identified the Regulatory Role of DNA Methylation in Relation to Histone Modifications

Additional File 12: Table S11. of Identification of Prognostic Signature in Cancer Based on DNA Methylation Interaction Network

Supplementary Data from Methylation of &lt;i&gt;tip30&lt;/i&gt; Promoter is Associated with Poor Prognosis in Human Hepatocellular Carcinoma

Supplementary Table S4 from Spatiotemporal Immune Landscape of Colorectal Cancer Liver Metastasis at Single-Cell Level

Supplementary Data from Methylation of <i>tip30</i> Promoter is Associated with Poor Prognosis in Human Hepatocellular Carcinoma